Population Pharmacokinetics
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 37 (1) , 41-58
- https://doi.org/10.2165/00003088-199937010-00003
Abstract
The application of population approaches to drug development is recommended in several US Food and Drug Administration (FDA) guidance documents. Population pharmacokinetic (and pharmacodynamic)...Keywords
This publication has 34 references indexed in Scilit:
- What are narrow therapeutic index drugs?Clinical Pharmacology & Therapeutics, 1998
- Ignorability and Parameter Estimation in Longitudinal Pharmacokinetic StudiesThe Journal of Clinical Pharmacology, 1998
- Role of Population Pharmacokinetics in Drug DevelopmentClinical Pharmacokinetics, 1997
- Direct Comparison of Three Methods For Predicting Digoxin ConcentrationsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1996
- Do we need full compliance data for population pharmacokinetic analysis?Journal of Pharmacokinetics and Biopharmaceutics, 1996
- Effect of misspecification of the absorption process on subsequent parameter estimation in population analysisJournal of Pharmacokinetics and Biopharmaceutics, 1993
- Population PharmacokineticsClinical Pharmacokinetics, 1986
- Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: Routine clinical pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1983
- Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1980